The NIHR Maudsley Biomedical Research Centre (BRC) provides a range of world-leading specialist research facilities. Together with a £3m grant from Guy's and St Thomas' Charity and South London and Maudsley NHS Foundation Trust, National Institute for Health Research (NIHR) funding has enabled the BRC to increase its translational research by investing in our core facilities:
The BioResource project, in collaboration with other BRCs, collects biological samples such as blood and saliva for molecular analysis, which are linked to electronic medical records of service users who have given permission to be contacted for participation in research.
The NIHR Maudsley BRC Nucleus is a state of the art facility established in 2009 as a result of a major infrastructure grant from South London and Maudsley NHS Foundation Trust and Guy's and St Thomas' Charities.
The Centre for Neuroimaging Sciences provides, under one roof, an interdisciplinary research environment that combines the development of contemporary, high resolution structural, functional and metabolic mapping techniques, with expertise in the definition, diagnosis and treatment of neurological and psychiatric disorders.
The Centre for Translational Informatics provides a functional interface between analytics, software development and implementation to promote digital innovation in mental health.
The Clinical Record Interactive Search (CRIS) system has been developed for use by the NIHR Maudsley BRC, and is now being rolled out to other NHS Trusts. It provides authorised researchers with regulated access to anonymised information extracted from South London and Maudsley NHS Foundation Trust electronic clinical records system.
The NIHR-Wellcome Trust King's Clinical Research Facility opened in November 2012. The building comprises of two main research areas within King's College Hospital Cheyne Wing. The Clinical Research Facility spans three floors with a further standalone unit, the Clinical Trials Facility.
The King’s Clinical Trials Unit helps research teams throughout the country carry out clinical trials safely and to a high scientific standard. It offers a range of services to help ensure the results are accurate and credible.
We offer access to a comprehensive suite of state-of-the-art omics platforms and specialist expertise, including bioinformatics and computational facilities and high throughput proteomics technologies.
Brings together the array of contributions the Institute of Psychiatry, Psychology & Neuroscience has made to this field and further promotes research in the area.
A High performance computing (HPC) and cloud facility which allows large-scale analysis of research data from sources as diverse as DNA samples to fitbits and health apps.
The South East London Community Health Study (SELCoH) study is an epidemiological cohort study of randomly selected households within the London boroughs of Southwark and Lambeth. It is providing locally relevant prevalence estimates of common mental disorders, such as depression and anxiety, and is examining the roles of historical social context and policy in shaping observed patterns of health inequalities.